NumFin

Guangdong Jiaying Pharmaceutical Co., Ltd

符号: 002198.SZ

SHZ

6.73

CNY

今天的市场价格

  • 121.8232

    市盈率

  • 10.9641

    PEG比率

  • 3.42B

    MRK市值

  • 0.00%

    DIV收益率

Guangdong Jiaying Pharmaceutical Co., Ltd (002198-SZ) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ). 的默认数据。公司收入显示 307.457 M 的平均值，即 0.183 % 增长率。整个期间的平均毛利润为 212.155 M，即 0.222 %. 平均毛利率为 0.632 %. 公司去年的净收入增长率为 -0.219 %，等于 2.301 % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 Guangdong Jiaying Pharmaceutical Co., Ltd 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.001. 在流动资产领域，002198.SZ 的报告货币为580.174. 这些资产中的很大一部分，即 334.037 是现金和短期投资。与去年的数据相比，该部分的变化率为0.427%. 公司的长期投资虽然不是其重点，但以报告货币计算的27.094（如果有的话）为27.094。这表明与上一报告期相比，-229.749% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 0. 这一数字表明，-1.000% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 762.985. 这方面的年同比变化率为 0.047%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为154.048，存货估值为 84.6，商誉估值为 0（如有. 无形资产总额（如果有）按 47.21 估值.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004

balance-sheet.row.cash-and-short-term-investments

1231.73334234.1239.4
142.2
122.3
114.9
82
73.3
46.2
33.3
56.3
21.6
10.5
30.3
32.9
81.9
153.6
37.5
21.5
2.4

balance-sheet.row.short-term-investments

660.9200.550.30
0
-51.3
0
-0.3
-4.6
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

657.68154240.6175.7
218.5
202.7
237.9
246.7
250.6
211.2
194.7
159.8
42.8
35.4
34.9
39
70.4
31.8
25.4
11.8
5.2

balance-sheet.row.inventory

347.5884.682.373.4
72.8
76.8
71.7
63.3
48.2
47.4
60
55.6
24.4
24.1
16.5
8.4
7.7
8
6.7
7.9
10.6

balance-sheet.row.other-current-assets

5.961.10.41.2
1
7.5
-20.1
-19.8
-21.5
-11
16.1
0.2
-0.6
-1.3
-1
-0.3
-1.5
-3.5
-1.7
-0.9
-0.1

balance-sheet.row.total-current-assets

2267.86580.2557.4489.7
434.5
409.3
404.5
372.3
350.6
293.8
304
271.9
88.2
68.7
80.7
80
158.5
189.8
67.8
40.4
18.1

balance-sheet.row.property-plant-equipment-net

769.11190.4203.7224.2
245.8
255.6
252.2
265
261.3
275.1
245
200.8
146.5
152.4
156
128.2
72.2
50.5
46.4
45.3
47.7

balance-sheet.row.goodwill

0000
0
0
120.8
120.8
360.9
360.9
360.9
360.9
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

191.4647.252.458.3
64.2
69.5
75.3
81.2
87.1
93
97.4
75.3
3.6
4.2
4.8
5.4
4.4
5.1
5.8
5.5
6.1

balance-sheet.row.goodwill-and-intangible-assets

191.4647.252.458.3
64.2
69.5
196.1
202
448
453.9
458.3
436.2
3.6
4.2
4.8
5.4
4.4
5.1
5.8
5.5
6.1

balance-sheet.row.long-term-investments

-134.0927.1-20.930.6
58.3
113.3
27.6
26.3
25.8
16.5
8.8
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

8.722.22.24.6
5.6
5
8.7
8.7
8.4
6.9
4.6
4.1
1.3
0.5
0.3
0.1
0.2
0.1
0.1
0
0

balance-sheet.row.other-non-current-assets

240.920.551.80
0.1
3.4
0.5
2.3
5.1
1.7
14.6
6
74.7
80.8
59.1
39.6
0
0
0
0
0

balance-sheet.row.total-non-current-assets

1076.11267.4289.2317.7
373.9
446.7
485.1
504.4
748.6
754.2
731.3
647.1
226
237.8
220.1
173.4
76.8
55.6
52.2
50.9
53.8

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

3343.97847.6846.7807.3
808.4
855.9
889.6
876.6
1099.3
1048
1035.3
919
314.2
306.5
300.9
253.3
235.2
245.5
120.1
91.2
71.9

balance-sheet.row.account-payables

42.139.21914.1
10.3
15.6
10.2
11.9
11.2
12.3
66.3
17.4
5.7
6.9
6.2
8.4
3.7
4.7
6.3
8.6
13.2

balance-sheet.row.short-term-debt

-2.0305.831.1
20.2
96.8
19
40
19.9
30.1
34
15
18.6
22.5
15
0
0
22
22
7.5
0

balance-sheet.row.tax-payables

28.037.517.212
11.2
9.7
17.2
16.9
22.5
20.2
17.4
17.4
0.9
0.5
0.6
0.1
2.7
3.2
4
0.4
0.2

balance-sheet.row.long-term-debt-total

0000
0
0
0
0
0
0
0
0
0
0
7.5
0
0
0
0
0
0

Deferred Revenue Non Current

1.720.40.50.2
0.2
0.3
0.3
0.5
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

139.12---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

118.6240.247.15.7
3.1
7.4
22.7
5.8
5.9
3.6
6.1
7.6
4.3
4
5
3.5
5.2
0.2
0.1
0.1
9.8

balance-sheet.row.total-non-current-liabilities

140.8435.235.334.9
35
35
35
35.2
34.7
34.7
34.7
34.7
0
0
7.5
0
0
0
0
0
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

315.9284.6118.2122.9
125.4
192.8
104.2
126.8
114.4
118.3
171.9
109.3
36.2
36
42.4
11.9
8.9
32.9
37.4
26.8
22.9

balance-sheet.row.preferred-stock

54.4527.200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

2030.04507.5507.5507.5
507.5
507.5
507.5
507.5
507.5
507.5
507.5
253.8
205
205
164
82
82
82
61.5
49.2
45.3

balance-sheet.row.retained-earnings

398.09104.670.326.3
24.9
5
127.2
91.7
326.7
276.6
211.6
158.9
30.1
23.7
55.2
65.3
51.7
39.4
17.4
12.9
3

balance-sheet.row.accumulated-other-comprehensive-income-loss

174.76027.227.2
27.2
27.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

370.71123.7123.4123.4
123.4
123.4
150.6
150.6
150.6
145.6
144.2
397
43
41.8
39.3
94.1
92.6
91.3
3.7
2.3
0.7

balance-sheet.row.total-stockholders-equity

3028.05763728.4684.5
683
663.2
785.4
749.8
984.9
929.7
863.3
809.7
278.1
270.5
258.5
241.4
226.3
212.6
82.6
64.4
49

balance-sheet.row.total-liabilities-and-stockholders-equity

3343.97847.6846.7807.3
808.4
855.9
889.6
876.6
1099.3
1048
1035.3
919
314.2
306.5
300.9
253.3
235.2
245.5
120.1
91.2
71.9

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

3028.05763728.4684.5
683
663.2
785.4
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

3343.97---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

105.9127.129.430.6
58.3
61.9
27.5
26
21.2
16.5
8.8
0
70.4
76.2
54.2
34.5
0
0
0
0
0

balance-sheet.row.total-debt

5.8705.831.1
20.2
96.8
19
40
19.9
30.1
34
15
18.6
22.5
22.5
0
0
22
22
7.5
0

balance-sheet.row.net-debt

-564.95-133.5-178.1-208.3
-122.1
-25.5
-95.9
-42
-53.4
-16.1
0.7
-41.3
-3
12
-7.8
-32.9
-81.9
-131.6
-15.5
-14
-2.4

现金流量表

在 Guangdong Jiaying Pharmaceutical Co., Ltd 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 2.825 的转变。该公司最近通过发行 0 扩大了股本，与上一年相比出现了0.000 的差异. 有趣的是，公司的部分股票，特别是 0，是由公司自己回购的。这一举动导致0.000 比上一年有所变化。同时，以报告货币计算，公司的应付账款目前为 44.11. 公司的投资活动产生了现金使用净额，按报告货币计算达到-51031607.190. 与上一年相比， -1.924 发生了变化. 在同一时期，公司记录了 25.89, -49.91 和 -31.11，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-0.45 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 0，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007200620052004

cash-flows.row.net-income

27.3243.91.519.8
-122.2
35.9
-214.8
55.2
66.4
73.7
139.5
7
20.2
25.2
15.1
13.7
24.4
22.1
15.4
2.8

cash-flows.row.depreciation-and-amortization

18.0125.928.428.2
27.2
27.1
26.7
25.7
21.4
23.5
14.9
14.8
14.5
11.9
7.5
6.3
5.4
4.3
4.1
2

cash-flows.row.deferred-income-tax

02.41-0.6
3.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0-2.4-10.6
-3.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

116.01-48.4-4.838.8
-16.1
-6.1
-27.5
-32.1
-46.1
0.7
11.6
-1.4
-14.4
1.1
11.4
-10
-13.3
-0.8
-2.7
3.6

cash-flows.row.account-receivables

118.37-86.59.69
-8.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-2.36-8.4-0.82.5
-4.9
-8.9
-14.5
-2.1
12.6
-4.4
-8.5
-0.3
-7.6
-8.2
-0.7
0.3
-1.4
1.3
2.7
-3.5

cash-flows.row.account-payables

044.1-14.727.9
-6.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

02.41-0.6
3.8
2.8
-13
-30
-58.6
5.1
20.1
-1.1
-6.8
9.3
12.1
-10.3
-11.9
-2.1
-5.3
7.2

cash-flows.row.other-non-cash-items

-48.065.726.710
124.1
5.2
246.1
4.3
0.7
5.5
-146.5
-15.2
-19.5
-18.6
-6
0.6
1.8
0.8
0.8
0.4

cash-flows.row.net-cash-provided-by-operating-activities

113.28000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-12.26-2.7-2.3-11.7
-18.8
-8.9
-18.4
-12
-33.4
-98.7
-8.7
-6.6
-10.8
-35.6
-76.9
-29.1
-8.7
-12.9
-6.1
-18

cash-flows.row.acquisitions-net

141.970.100
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0-0.100
-86.3
0
-4.3
-2.5
-7
-8.8
0
0
0
0
0
-28.9
0
0
0
0

cash-flows.row.sales-maturities-of-investments

-126.831.632.518.5
0
0
0
0
0
0
5.3
17.8
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

-180-49.925.1-25
0
2.2
2.5
0.1
16.3
-15.8
37.1
0
0
0
0
0
0
0
0.1
0

cash-flows.row.net-cash-used-for-investing-activites

-176.93-5155.2-18.2
-105.1
-6.8
-20.2
-14.4
-23.1
-123.2
33.7
11.2
-10.8
-35.6
-76.9
-57.9
-8.7
-12.9
-6
-18

cash-flows.row.debt-repayment

0-31.1-15-135
-19
-58
-19.9
-30.1
-41
-15
-18.6
-22.5
-15
-7.5
0
-22
-22
-15
0
0

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-0.5-1-3.8
-3.5
-1.3
-21.9
-1.4
-2.4
-22.2
-7.6
-1.4
-9.8
-9.1
0
-0.5
-1.4
-5.1
0
0

cash-flows.row.other-financing-activites

0031.155
122
37
40
19.9
45.6
26.7
6.6
18.6
15
30
0
-2
129.8
22.6
7.5
6.9

cash-flows.row.net-cash-used-provided-by-financing-activities

0-31.615.1-83.8
99.5
-22.3
-1.8
-11.6
2.2
-10.5
-19.6
-5.4
-9.8
13.4
0
-24.5
106.4
2.6
7.5
6.9

cash-flows.row.effect-of-forex-changes-on-cash

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

-64.89-55.4122.1-5.1
7.4
33
8.6
27.1
21.4
-30.4
33.6
11.1
-19.8
-2.6
-49
-71.7
116
16
19.1
-2.4

cash-flows.row.cash-at-end-of-period

567.95183.9239.3117.2
122.3
114.9
82
73.3
46.2
24.8
55.2
21.6
10.5
30.3
32.9
81.9
153.6
37.5
21.5
2.4

cash-flows.row.cash-at-beginning-of-period

632.85239.3117.2122.3
114.9
82
73.3
46.2
24.8
55.2
21.6
10.5
30.3
32.9
81.9
153.6
37.5
21.5
2.4
4.8

cash-flows.row.operating-cash-flow

113.2827.251.896.9
13
62.1
30.6
53.1
42.3
103.4
19.5
5.3
0.8
19.7
28
10.7
18.3
26.4
17.6
8.8

cash-flows.row.capital-expenditure

-12.26-2.7-2.3-11.7
-18.8
-8.9
-18.4
-12
-33.4
-98.7
-8.7
-6.6
-10.8
-35.6
-76.9
-29.1
-8.7
-12.9
-6.1
-18

cash-flows.row.free-cash-flow

101.0224.449.585.2
-5.9
53.2
12.2
41.1
8.9
4.6
10.7
-1.3
-10
-15.9
-49
-18.3
9.7
13.4
11.5
-9.3

利润表行

Guangdong Jiaying Pharmaceutical Co., Ltd 的收入与上期相比变化了 -0.191%。据报告, 002198.SZ 的毛利润为 347.72。该公司的营业费用为 310.41，与上年相比变化了 -17.437%. 折旧和摊销费用为 25.89，与上一会计期间相比变化了 -0.091%. 营业费用报告为 310.41，显示-17.437% 的同比变化。 销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。 基于近期数据的EBITDA为 0，同比增长-0.248%. 营业收入为 40.52，与上年相比变化了-0.248%. 净利润的变化率为 -0.219%。去年的净收入为34.32.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004

income-statement-row.row.total-revenue

499.15533.2659.2574.7
544.7
500.5
537
468.1
450
475.8
565.8
226.7
104.5
85.9
75.2
62.3
66.3
64.6
62.7
54.3
37.5

income-statement-row.row.cost-of-revenue

184.54185.5228.5141.9
146.5
106.4
144
125
104.7
126.7
221.3
96.8
52.1
45.1
34.2
25.8
26.9
23.9
24.1
24.6
22

income-statement-row.row.gross-profit

314.61347.7430.7432.8
398.2
394.1
393
343
345.2
349.1
344.6
130
52.4
40.8
41
36.5
39.5
40.7
38.6
29.7
15.5

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

10.47---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

13.37---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

219.49---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-1.19-1.140.746.3
42.9
47.1
0.5
1.1
0
3.9
11.4
4
2
1.2
3.5
2.7
2.6
6.4
1.6
0.5
0.5

income-statement-row.row.operating-expenses

285.61310.4376403.2
365.2
384.6
346.1
304.6
274.5
274.2
263.1
101.2
62
40.7
36.8
28.6
27.4
15.3
14.9
13.5
12.3

income-statement-row.row.cost-and-expenses

470.15495.9604.5545.1
511.7
491
490.1
429.6
379.2
400.9
484.3
198
114.1
85.8
71
54.4
54.2
39.1
39
38.1
34.2

income-statement-row.row.interest-income

2.172.12.32.6
1.1
0.5
0.4
0.3
0.1
0.2
0.3
0.1
0
0.2
0.2
0.3
1.3
0.2
0.2
0
0

income-statement-row.row.interest-expense

000.51
3.7
3.5
1.8
1.8
1.5
2.4
2.2
1.5
1.4
1.6
0.9
0
0.5
1.5
0.3
0.5
0.5

income-statement-row.row.selling-and-marketing-expenses

219.49---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0.142.1-2.8-27.8
-1
-123.1
-4.6
-244.3
-4.1
3.4
5.8
150.5
16.7
20.7
21.9
8.9
3.9
3.3
0.9
-0.8
-0.4

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-1.19-1.140.746.3
42.9
47.1
0.5
1.1
0
3.9
11.4
4
2
1.2
3.5
2.7
2.6
6.4
1.6
0.5
0.5

income-statement-row.row.total-operating-expenses

0.142.1-2.8-27.8
-1
-123.1
-4.6
-244.3
-4.1
3.4
5.8
150.5
16.7
20.7
21.9
8.9
3.9
3.3
0.9
-0.8
-0.4

income-statement-row.row.interest-expense

000.51
3.7
3.5
1.8
1.8
1.5
2.4
2.2
1.5
1.4
1.6
0.9
0
0.5
1.5
0.3
0.5
0.5

income-statement-row.row.depreciation-and-amortization

8.9124.226.628.4
33.5
27.2
27.1
26.7
25.7
21.4
23.5
14.9
14.8
14.5
11.9
7.5
6.3
5.4
4.3
4.1
2

income-statement-row.row.ebitda-caps

30.17---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

33.6540.553.933.6
24.1
8.9
41.8
-206.9
66.7
74.4
76.2
176.3
5
19.6
22.7
14
12.7
23.7
23.1
15.5
2.8

income-statement-row.row.income-before-tax

32.4639.451.15.8
23
-114.2
42.3
-205.8
66.6
78.2
87.3
179.3
7
20.8
26.2
16.8
16.1
28.8
24.6
15.4
2.8

income-statement-row.row.income-tax-expense

5.155.17.24.3
3.2
8
6.5
8.9
11.5
11.9
13.7
39.8
-0.5
0.6
0.9
1.7
2.3
4.4
2.5
0
0.1

income-statement-row.row.net-income

27.3234.343.91.5
19.8
-122.2
35.9
-214.8
55.2
66.4
73.7
139.5
7.6
20.2
25.2
15.1
13.7
24.4
22.1
15.4
2.8
类似股票
您可能还对以下内容感兴趣：
MARKSANS.NS
Marksans Pharma Limited.
165.95 INR
NSE
2186.HK
Luye Pharma Group Ltd..
3.04 HKD
HKSE
PTKFY
PT Kalbe Farma Tbk..
17.03 USD
PNK
VIRP.PA
Virbac SA.
334 EUR
EURONEXT
DSKYF
Daiichi Sankyo Company, Limited.
36.41 USD
PNK
ALPMF
Astellas Pharma Inc..
9.521 USD
PNK
NGLFINE.NS
NGL Fine-Chem Limited.
2128.05 INR
NSE
BMY
Bristol-Myers Squibb Company.
43.99 USD
NYSE
ORNBV.HE
Orion Oyj.
36.12 EUR
HEL
CHGCF
Chugai Pharmaceutical Co., Ltd..
32.43 USD
PNK
GRFS
Grifols, S.A..
6.57 USD
NASDAQ

常见问题

什么是 Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ) 总资产是多少？

Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ) 总资产为 847563113.000.

什么是企业年收入？

年收入为 250417163.000.

企业利润率是多少？

公司利润率为 0.630.

什么是公司自由现金流？

自由现金流为 0.199.

什么是企业净利润率？

净利润率为 0.055.

企业总收入是多少？

总收入为 0.067.

什么是 Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 34320234.000.

公司总债务是多少？

债务总额为 0.000.

营业费用是多少？

运营支出为 310409681.000.

公司现金是多少？

企业现金为 118503980.000.